Mixed cryoglobulinemia and HCV

Annals of Gastroenterology

Volumn 15, Issue 1, 2002, Pages 36-40

  Tassopoulos, Nicholas C ^a   Papageorgiou, Johanna N ^b  

^a Western Attica General Hospital   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

Hepatitis C virus; Interferon alfa; Mixed cryoglobulinemia; Non Hogkin's lymphoma

Indexed keywords

ALPHA INTERFERON; COMPLEMENT; CRYOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; RIBAVIRIN;

ANTIGEN ANTIBODY COMPLEX; ARTHRALGIA; ASTHENIA; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; ERADICATION THERAPY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY DISEASE; LOW TEMPERATURE; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PRECIPITATION; PURPURA; REVIEW; VASCULITIS; WARMING;

EID: 35649015356     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Brouet JC, Clouvel JP, Dannon F, et al. Biologic and clinical significance of cryoglobulins. Am J Med 1974; 57:775-788.
2. Musset L, Diemert MC, Taibi F, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992; 38:798-802.
3. Tissot JD, Schifferl JA, Hochstasser DF, et al. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide. J Immunol Meth 1994; 173:63-75.
4. Musset L, Duarte F, Gaillard O, et al. Immunochemical characterization of monoclonal IgG containing mixed cryoglobulins. Clin Immunol Immunopathol 1994; 70:166-170.
5. Gorevic PD, Kassab HJ, Levo Y et al. Mixed cryoglobulinemia clinical aspects and long-term follow up of 40 patients. Am J Med 1980; 69:287-308.
6. Meltzer M, Franklin EC, Elias E et al. Cryoglobulinemia: a clinical and laboratory study. Am J Med 1966; 40:817-856.
7. Ferri G Marzo E, Longomardo G, et al, Inteferon -alpha in mixed cryoglobulinemia patients: randomized, crossover-controlled trial. Blood 1983; 81:1132-1136.
8. Agnello V, Chung RT, Kaplan LM. A role of hepatitis C infection in type N cryoglobulinemia. N Engl J Med 1992; 327:1490-1495.
9. Cacoub P, Haussfater P, Musset L, et al. Mixed cryoglobulinemia in hepatitis C patients. Ann Med Interne 2000; 151:20-29.
10. L'Abbate A, Cutrupi S, Rognetta M, et al. IgM and IgG antibodies to hepatitis C virus in patients with.mixed cryoglobulinemia. Clin Exp Immunol 1993; 94:313-316.
11. Aiyama T, Yoshioka,Y, Okumura A, et al. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: Relationship to antibody response against hypervariable region genome. Hepatology 1996; 24:1346-1350
12. Wong VS, Egner W, Elsey T,Brown D, et al. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C infection. Clin Exp Immunol 1996; 104:25-31.
13. Fornasieri A, Armelioni S, Bemasconi P et al. High binding to cellular fibronectin: mechanism for induction of. in situ immune complex glomerulorephritis. Am J Kidney Dis. 1996; 27:476-483.
14. Mecchia M, Casato M, Tafi R, et al. Nonrheumatoid IgM in human hepatitis C virus-associated type II cryoglobulinemia recognized mimitopes of the CD4-likeLAG-3 protein. J Immunol 1996; 157:3727-3736.
15. Thomssen R, Bonk S, Thiele A. Density heterogeneities ofHCV in human sera due to the binding ofbeta-lipoproteins and immunoglobulins. Med Microbiol Immunol Berl 1993; 182:329-334.
16. Coulie PG, Van Snick J. Rheumatoid factor (RF) production during anamnestic immune response in mouse III. Activation of RF precursor cells is induced by their interaction with immune complexes and carrier-specific helper T cells. J Exp Med, 1985; 161:88-97.
17. Bachmann MF, Kundig TM, Hangartner H, et al. Regulation ofIgG antibody titers by the. amount persisting of immune-complexed antigen. Eur J Immunol, 1994; 2567-2570.
18. Sansonno D, Cornacchiulo V, Jacobelli AR, et al. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus infected patients with mixed cryoglobylinemia Hepatology 1995; 21:305-312.
19. Horcajada JP. Garcia-Bengoechea M, Gilla G, et al. Mixed cryoglobulinemia in patients with chronic hepatitis C infection;prevalence significance and relationship with different viral genotypes. Ann Med 1999; 31:352-358.
20. Fayyazzi A, Schott P, Hartmann H, et al. Clinical, biochemical and histological changes in hepatitis C virus infection-associated cryoglobulinemia Z. Gastroenterol 1997; 35:921-928
21. Sinico RA, Ribero ML, Fornasieri A, et al. Hepatitis C virus genotype in patients with essential mixed cryoglobulinemic Q J Med 1995; 88:805-810.
22. Zignego A, Ferri C, Gianni C, et al. Hepatitis C genotype analysis in patients with Type II mixed cryoglobulinemia. Ann Intern Med 1996; 124:31-34.
23. Kerr GS, Rofail M, Lewis JH, et al Prevalence ofHCV associated cryoglobulinemia at a Veterans Hospital. J Rhemmatol 1997; 24:2134-2138.
24. Abrahamian GA, CosimiAB, Farrell ML, et al. Prevalence ofHCV-associated mixed cryoglobulinemia after liver transplantation. Liver Transpi 2000; 6:185-190.
25. Ferri C, La Civita L, Zignego AL, et al. Viruses and cancer: possible role of hepatitis C virus. Eur J Clin Invest 1997; 27:711-718.
26. Ferri C, La Civita L, Longombardo G, et al. Mixed cryoglobulinemia: a cross-road between autoimmune and lymphoproliferative disorders.Lupus 1998; 7:275-279.
27. Valentini G, Mantelli A, Persico M, et al. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions. Clin Exp Rheumatol 1999; 17:75-79
28. Casato M, Agnello V, Pucillo LR et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with HCV infection. Blood 1997; 90:3865-3873.
29. Missiani R,Bellavita P, Fenili D et al. Interferon alfa 2a therapy in cryoglobulinemia associated with HCV. N Engl J Med 1994; 330:751-756.
30. Cresta P. Musset L, Cacoub L et al Response to interferon a treatment and disappearance of cryoglobulinemia in patients infected by HCV. Gut 1999; 45:122-128.
31. Adenolfi LE, Util i R, Zampino P, et al. Effects of long-term course ofalpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinemia. Eur J Gastroeterol Hepatol 1997; 9:1067-1072.
32. Calleja JL, Albillos A, Moreno-Otero R, et al. Sustained response to interferon-a or to interferon-a plus ribavirin in hepatitis C virus-associated symptomatic mixed cryglobulinemia. Aliment Pharmacol Ther 1999; 13:1179-1186.
33. Donada C, Grucitti A Donadon V, et al. Interferon-a and ribavirin therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Blood 1998; 12:2983-2984.